Literature DB >> 32407787

Universal severe acute respiratory syndrome coronavirus 2 testing of pregnant women admitted for delivery in 2 Italian regions.

Luigi Gagliardi1, Roberto Danieli2, Giovanni Suriano3, Angelina Vaccaro4, Gino Tripodi5, Franca Rusconi6, Luca A Ramenghi7.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32407787      PMCID: PMC7215152          DOI: 10.1016/j.ajog.2020.05.017

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


× No keyword cloud information.

Background

Since the early days of the coronavirus disease 2019 (COVID-19) pandemic, substantial undocumented infection has been thought to contribute to the dissemination of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with estimated percentages of undocumented infections of 72%–90%.1, 2, 3 Italy has been the first western country to be massively hit by the pandemic. On March 11, the Italian government ordered the country lockdown, which is still in place as of this writing. This led to a flattening and eventually a reduction of the pandemic curve. Starting by the end of March, several hospitals have begun universal SARS-CoV-2 screening in all admitted patients. Women admitted for delivery represent a peculiar population and a unique source of information, because they come to hospitals independent of illness and of their own decision. They can therefore provide useful estimates of the circulation of the virus in the general population, despite a possible different social behavior, especially near delivery.

Objective

This study aimed to estimate the “true” SARS-CoV-2 infection rate among women admitted for delivery and estimate the burden of undocumented infections in this population.

Methods

We studied 2 neighboring Italian regions, North of Tuscany and Liguria, both considered at medium risk of infection compared with the Northern regions. All 6 hospitals of Azienda USL “Toscana Nord Ovest” (ATNO, Tuscany) and Gaslini Children’s Hospital (Genoa, Liguria) began SARS-CoV-2 screening between March 26, 2020, and April 1, 2020, by nasopharyngeal swab (real-time reverse transcription polymerase chain reaction). Informed consent was obtained from all women.

Results

Up to April 19, 2020, 533 women were admitted for delivery (ATNO, 344; Gaslini, 189). Of these, 3 from ATNO received positive results (1 only had anosmia and 2 were asymptomatic): all gave birth without clinical problems for the mother and the neonate. The estimated prevalence in this sample was 0.56% (3/533; 95% confidence interval, 0.19–1.64). During the study period, the overall prevalence of positive cases reported by the Italian COVID-19 Surveillance System in women aged 20–39 years in Tuscany was 0.094%. From these data, we can estimate that 83% (51–94) of infections were unreported, that is, the real prevalence risk of the general population of women of this age is 6 (2–11) times the rate found in women tested for clinical reasons.

Conclusion

Our estimated risk of undocumented infection in pregnant women, obtained in a population at a “steady state” for virus circulation and during a country lockdown, confirmed earlier estimates of about 4–9 undetected cases to 1 case detected because of symptoms. Interestingly, these ratios were confirmed even in completely different settings like hospitals in New York, , where both the prevalence of infection at delivery among asymptomatic women who would not be otherwise tested (13.5% and 13%) and baseline risk in the population (1.4%) are more than 1 order of magnitude greater than in Tuscany. The small number of positive cases in our sample does not allow a precise estimate, but the substantial stability of the ratio of undocumented to documented infections in different populations and using different methodologies1, 2, 3 , , suggests that these results are generalizable. We concur that a strategy of universal testing in all pregnant women admitted for delivery is warranted to control further spread of the virus and, above all, to protect the women themselves, their newborns, and the healthcare staff against the infection.
  5 in total

1.  Screening all pregnant women admitted to labor and delivery for the virus responsible for coronavirus disease 2019.

Authors:  William S Vintzileos; Jolene Muscat; Eva Hoffmann; Nicole S John; Rosanne Vertichio; Anthony M Vintzileos; Duc Vo
Journal:  Am J Obstet Gynecol       Date:  2020-04-26       Impact factor: 8.661

2.  The Rate of Underascertainment of Novel Coronavirus (2019-nCoV) Infection: Estimation Using Japanese Passengers Data on Evacuation Flights.

Authors:  Hiroshi Nishiura; Tetsuro Kobayashi; Yichi Yang; Katsuma Hayashi; Takeshi Miyama; Ryo Kinoshita; Natalie M Linton; Sung-Mok Jung; Baoyin Yuan; Ayako Suzuki; Andrei R Akhmetzhanov
Journal:  J Clin Med       Date:  2020-02-04       Impact factor: 4.241

3.  Estimation of COVID-19 outbreak size in Italy.

Authors:  Ashleigh R Tuite; Victoria Ng; Erin Rees; David Fisman
Journal:  Lancet Infect Dis       Date:  2020-03-19       Impact factor: 25.071

4.  Universal Screening for SARS-CoV-2 in Women Admitted for Delivery.

Authors:  Desmond Sutton; Karin Fuchs; Mary D'Alton; Dena Goffman
Journal:  N Engl J Med       Date:  2020-04-13       Impact factor: 91.245

5.  Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2).

Authors:  Ruiyun Li; Sen Pei; Bin Chen; Yimeng Song; Tao Zhang; Wan Yang; Jeffrey Shaman
Journal:  Science       Date:  2020-03-16       Impact factor: 47.728

  5 in total
  15 in total

1.  Universal Sars-Cov-2 Screening in Pregnant Women: Experience from the Italian Epidemic Outbreak.

Authors:  Elena Grossi; Benedetta Agnoli; Monica Baldini; Simona Illari; Renza Bonini; Giuseppe Scagnelli
Journal:  Acta Biomed       Date:  2021-03-31

2.  SARS-CoV-2 prevalence and maternal-perinatal outcomes among pregnant women admitted for delivery: Experience from COVID-19-dedicated maternity hospital in Jammu, Jammu and Kashmir (India).

Authors:  Puneet Gupta; Surender Kumar; Shashi S Sharma
Journal:  J Med Virol       Date:  2021-05-24       Impact factor: 20.693

3.  Universal screening identifies asymptomatic carriers of SARS-CoV-2 among pregnant women in India.

Authors:  Rakesh Waghmare; Rahul Gajbhiye; Niraj N Mahajan; Deepak Modi; Sanjay Mukherjee; Smita D Mahale
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2020-09-23       Impact factor: 2.435

4.  Lessons learnt in transitioning from universal screening to universal testing of pregnant patients for SARS-CoV-2 at the largest municipal health system in America.

Authors:  Wendy Wilcox; Komal Bajaj; Max C Rossberg; Clementine Knight; Daryl Wieland; Yogangi Malhotra
Journal:  J Perinatol       Date:  2021-01-18       Impact factor: 2.521

Review 5.  Samba II PCR testing for COVID-19 in pregnant women: a retrospective cohort study and literature review.

Authors:  Ruiling Xu; Tara Alicia Pauley; Hannah Missfelder-Lobos; Richard John Haddon; Ravindra Kumar Gupta; Hsu Phern Chong
Journal:  BMC Pregnancy Childbirth       Date:  2021-03-17       Impact factor: 3.007

6.  Patient characteristics associated with SARS-CoV-2 infection in parturients admitted for labour and delivery in Massachusetts during the spring 2020 surge: A prospective cohort study.

Authors:  Sharon C Reale; Mario I Lumbreras-Marquez; Chih H King; Stacey L Burns; Kara G Fields; Khady Diouf; Ilona T Goldfarb; Andrea L Ciaranello; Julian N Robinson; Katherine E Gregory; Krista F Huybrechts; Brian T Bateman
Journal:  Paediatr Perinat Epidemiol       Date:  2021-01       Impact factor: 3.980

7.  Seroprevalence analysis of SARS-CoV-2 in pregnant women along the first pandemic outbreak and perinatal outcome.

Authors:  Cecilia Villalaín; Ignacio Herraiz; Joanna Luczkowiak; Alfredo Pérez-Rivilla; María Dolores Folgueira; Inmaculada Mejía; Emma Batllori; Eva Felipe; Beatriz Risco; Alberto Galindo; Rafael Delgado
Journal:  PLoS One       Date:  2020-11-30       Impact factor: 3.240

8.  Routine screening for SARS CoV-2 in unselected pregnant women at delivery.

Authors:  Pilar Díaz-Corvillón; Max Mönckeberg; Antonia Barros; Sebastián E Illanes; Arturo Soldati; Jyh-Kae Nien; Manuel Schepeler; Javier Caradeux
Journal:  PLoS One       Date:  2020-09-29       Impact factor: 3.240

9.  Transmission of SARS-CoV-2 through breast milk and breastfeeding: a living systematic review.

Authors:  Elizabeth Centeno-Tablante; Melisa Medina-Rivera; Julia L Finkelstein; Pura Rayco-Solon; Maria Nieves Garcia-Casal; Lisa Rogers; Kate Ghezzi-Kopel; Pratiwi Ridwan; Juan Pablo Peña-Rosas; Saurabh Mehta
Journal:  Ann N Y Acad Sci       Date:  2020-08-28       Impact factor: 5.691

10.  COVID-19 and pregnancy: A review of clinical characteristics, obstetric outcomes and vertical transmission.

Authors:  Elicia Pettirosso; Michelle Giles; Stephen Cole; Megan Rees
Journal:  Aust N Z J Obstet Gynaecol       Date:  2020-08-10       Impact factor: 1.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.